Mucosal flora in Crohn's disease and ulcerative colitis - an overview

Area of Science:

• Microbiology
• Gastroenterology
• Immunology

Background:

• The intestinal microbiota contains potentially pathogenic bacteria, normally separated from the colonic wall by a mucus layer.
• In inflammatory bowel disease (IBD), this mucus barrier is defective, leading to bacterial adherence, epithelial invasion, and chronic inflammation.
• The precise cause of mucus barrier defects in IBD remains unclear, though lifestyle factors and food additives are implicated.

Purpose of the Study:

• To investigate the biostructure of the intestinal microbiota in IBD patients.
• To explore the relationship between mucus barrier integrity and the gut microbiota composition.
• To identify specific microbiota changes associated with active Crohn's disease and ulcerative colitis.

Main Methods:

• Analysis of the biostructure of faecal microbiota.
• Longitudinal monitoring of microbiota changes in IBD patients.
• Review of epidemiological data linking IBD incidence to lifestyle and food components.

Main Results:

• Defective mucus barrier in IBD patients allows bacterial translocation and triggers inflammatory responses.
• Chronic inflammation and defective mucus barrier lead to characteristic, monitorable changes in faecal microbiota biostructure.
• These microbiota alterations are specific to active Crohn's disease and ulcerative colitis.

Conclusions:

• The integrity of the colonic mucus barrier is crucial for maintaining host tolerance to intestinal bacteria.
• Alterations in the intestinal microbiota's biostructure are specific biomarkers for active IBD.
• Further investigation into the role of environmental factors, such as detergents and emulsifiers, on mucus barrier function is warranted.